Loading chat...

FL H2945

Bill

Status

Introduced

11/15/2021

Primary Sponsor

Demi Busatta Cabrera

Click for details

Origin

House of Representatives

2022 Regular Session

AI Summary

  • Appropriates $796,706 from the General Revenue Fund to the Department of Children and Families for fiscal year 2022-2023
  • Funds the DCF Extended-Release Injectable Naltrexone (Vivitrol) Program as described in Appropriations Project Request 536
  • Designates the appropriation as nonrecurring funding
  • Effective date is July 1, 2022

Legislative Description

Department of Children and Families (DCF) Extended-Release Injectable Naltrexone (Vivitrol) Program

Last Action

See HB 5001 (line item 371)

3/14/2022

Committee Referrals

Appropriations1/28/2022
Health Care Appropriations Subcommittee11/23/2021

Full Bill Text

No bill text available